Skip to main content
. 2024 Feb 19;2024:4002839. doi: 10.1155/2024/4002839

Table 4.

Odds ratio (95% CI) for prevalent hyperuricemia by quartiles of AIP in longitudinal analysis.

Quartiles of AIP Q1 Q2 Q3 Q4 P for trend
Cases 107 114 185 258
Prevalence (%) 5.92 6.48 10.37 15.48
Model 1 1.00 (reference) 1.10 (0.84–1.45) 1.84 (1.44–2.36)∗∗∗ 2.91 (2.30–3.69)∗∗∗ <0.001
Model 2 1.00 (reference) 1.17 (0.86–1.55) 1.95 (1.51–2.52)∗∗∗ 3.21 (2.52–4.10)∗∗∗ <0.001
Model 3 1.00 (reference) 1.04 (0.77–1.40) 1.65 (1.25–2.17)∗∗∗ 2.58 (1.97–3.38)∗∗∗ <0.001
Model 4 1.00 (reference) 1.01 (0.75–1.37) 1.59 (1.20–2.10)∗∗∗ 2.53 (1.93–3.33)∗∗∗ <0.001
Model 5 1.00 (reference) 1.00 (0.74–1.37) 1.59 (1.20–2.11)∗∗∗ 2.55 (1.94–3.35)∗∗∗ <0.001

Odds ratio (95% CI) for prevalent hyperuricemia by quartiles of AIP in longitudinal analysis. The adjusting variables were the same as Table 2. p  <  0.05; ∗∗p  <  0.01; ∗∗∗p  <  0.001.